| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4241039 | Journal of Vascular and Interventional Radiology | 2010 | 8 Pages |
Abstract
Yttrium-90 microspheres are tolerated in patients with HCC and major PVT. Compared with chemoembolization, rates of severe adverse events appear low. Radiographic response rates are low. The median OS of 7 months is promising and warrants further study versus systemic therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Andrea Lan MA, Charles T. MD, Andrew S. MD, Dominic T. PhD, Matthew A. MD, Robert D. MD, Joseph M. MD, Stephen A. MD, Amir H. MD, Bert H. MD,